Cargando…

Adenosine triphosphate-based tumor chemosensitivity assay may predict the clinical outcomes of gastric cancer patients receiving taxane-based post-operative adjuvant chemotherapy

Detalles Bibliográficos
Autores principales: Bian, Yicong, Huang, Minzhou, Ma, Sheng, Liu, Linsheng, Xia, Fan, Chen, Zhiyao, Yu, Di, Huang, Chenrong, Miao, Liyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433078/
https://www.ncbi.nlm.nih.gov/pubmed/35838415
http://dx.doi.org/10.1097/CM9.0000000000002210
_version_ 1784780545766457344
author Bian, Yicong
Huang, Minzhou
Ma, Sheng
Liu, Linsheng
Xia, Fan
Chen, Zhiyao
Yu, Di
Huang, Chenrong
Miao, Liyan
author_facet Bian, Yicong
Huang, Minzhou
Ma, Sheng
Liu, Linsheng
Xia, Fan
Chen, Zhiyao
Yu, Di
Huang, Chenrong
Miao, Liyan
author_sort Bian, Yicong
collection PubMed
description
format Online
Article
Text
id pubmed-9433078
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94330782022-09-01 Adenosine triphosphate-based tumor chemosensitivity assay may predict the clinical outcomes of gastric cancer patients receiving taxane-based post-operative adjuvant chemotherapy Bian, Yicong Huang, Minzhou Ma, Sheng Liu, Linsheng Xia, Fan Chen, Zhiyao Yu, Di Huang, Chenrong Miao, Liyan Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2022-06-05 2022-07-13 /pmc/articles/PMC9433078/ /pubmed/35838415 http://dx.doi.org/10.1097/CM9.0000000000002210 Text en Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Correspondence
Bian, Yicong
Huang, Minzhou
Ma, Sheng
Liu, Linsheng
Xia, Fan
Chen, Zhiyao
Yu, Di
Huang, Chenrong
Miao, Liyan
Adenosine triphosphate-based tumor chemosensitivity assay may predict the clinical outcomes of gastric cancer patients receiving taxane-based post-operative adjuvant chemotherapy
title Adenosine triphosphate-based tumor chemosensitivity assay may predict the clinical outcomes of gastric cancer patients receiving taxane-based post-operative adjuvant chemotherapy
title_full Adenosine triphosphate-based tumor chemosensitivity assay may predict the clinical outcomes of gastric cancer patients receiving taxane-based post-operative adjuvant chemotherapy
title_fullStr Adenosine triphosphate-based tumor chemosensitivity assay may predict the clinical outcomes of gastric cancer patients receiving taxane-based post-operative adjuvant chemotherapy
title_full_unstemmed Adenosine triphosphate-based tumor chemosensitivity assay may predict the clinical outcomes of gastric cancer patients receiving taxane-based post-operative adjuvant chemotherapy
title_short Adenosine triphosphate-based tumor chemosensitivity assay may predict the clinical outcomes of gastric cancer patients receiving taxane-based post-operative adjuvant chemotherapy
title_sort adenosine triphosphate-based tumor chemosensitivity assay may predict the clinical outcomes of gastric cancer patients receiving taxane-based post-operative adjuvant chemotherapy
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433078/
https://www.ncbi.nlm.nih.gov/pubmed/35838415
http://dx.doi.org/10.1097/CM9.0000000000002210
work_keys_str_mv AT bianyicong adenosinetriphosphatebasedtumorchemosensitivityassaymaypredicttheclinicaloutcomesofgastriccancerpatientsreceivingtaxanebasedpostoperativeadjuvantchemotherapy
AT huangminzhou adenosinetriphosphatebasedtumorchemosensitivityassaymaypredicttheclinicaloutcomesofgastriccancerpatientsreceivingtaxanebasedpostoperativeadjuvantchemotherapy
AT masheng adenosinetriphosphatebasedtumorchemosensitivityassaymaypredicttheclinicaloutcomesofgastriccancerpatientsreceivingtaxanebasedpostoperativeadjuvantchemotherapy
AT liulinsheng adenosinetriphosphatebasedtumorchemosensitivityassaymaypredicttheclinicaloutcomesofgastriccancerpatientsreceivingtaxanebasedpostoperativeadjuvantchemotherapy
AT xiafan adenosinetriphosphatebasedtumorchemosensitivityassaymaypredicttheclinicaloutcomesofgastriccancerpatientsreceivingtaxanebasedpostoperativeadjuvantchemotherapy
AT chenzhiyao adenosinetriphosphatebasedtumorchemosensitivityassaymaypredicttheclinicaloutcomesofgastriccancerpatientsreceivingtaxanebasedpostoperativeadjuvantchemotherapy
AT yudi adenosinetriphosphatebasedtumorchemosensitivityassaymaypredicttheclinicaloutcomesofgastriccancerpatientsreceivingtaxanebasedpostoperativeadjuvantchemotherapy
AT huangchenrong adenosinetriphosphatebasedtumorchemosensitivityassaymaypredicttheclinicaloutcomesofgastriccancerpatientsreceivingtaxanebasedpostoperativeadjuvantchemotherapy
AT miaoliyan adenosinetriphosphatebasedtumorchemosensitivityassaymaypredicttheclinicaloutcomesofgastriccancerpatientsreceivingtaxanebasedpostoperativeadjuvantchemotherapy